Inspections, Compliance, Enforcement, and Criminal Investigations
Lone Star Lions Eye Bank Closeout Letter 5/25/12
| Public Health Service Food and Drug Administration |
| Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 |
May 25, 2012
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Mr. Michael A. Wilson, President
Board of Directors
Lone Star Lions Eye Bank, Inc.
1 02 East Wheeler Street
Manor, Texas 78653
Dear Mr. Wilson:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 2012-DAL-WL-09, December 12, 2011. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Shari J. Shambaugh
Director, Compliance Branch





Department of Health and Human Services

